Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia–reperfusion injury through a multistage continuous targeted strategy
Y Cheng, D Liu, C Zhang, H Cui, M Liu, Q Mei… - … , Biology and Medicine, 2019 - Elsevier
Efficient delivery of antioxidant drugs into mitochondria of ischemic cardiomyocytes where
reactive oxygen species largely induced is a major challenge for precise treatment of …
reactive oxygen species largely induced is a major challenge for precise treatment of …
Scaffold thrombosis: Exaggerated illusion, or when statistics rules
AN Kharlamov - International Journal of …, 2016 - internationaljournalofcardiology.com
For some, bioresorbable vascular scaffolds (BVS) represent one of the most promising
technologies in interventional cardiology, but in recent months, multiple reports examining …
technologies in interventional cardiology, but in recent months, multiple reports examining …
[HTML][HTML] Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials
AN Kharlamov - World Journal of Cardiology, 2018 - ncbi.nlm.nih.gov
AIM To statistically examine the released clinical trials and meta-analyses of polymeric
bioresorbable scaffolds resuming the main accomplishments in the field with a translation to …
bioresorbable scaffolds resuming the main accomplishments in the field with a translation to …
WITHDRAWN: What exactly, regression of atherosclerosis or foreign body reaction with hyaline arteriosclerosis, drives transient scaffolding of coronary arteries? A …
AN Kharlamov, JA Feinstein… - International …, 2017 - pubmed.ncbi.nlm.nih.gov
WITHDRAWN: What exactly, regression of atherosclerosis or foreign body reaction with hyaline
arteriosclerosis, drives transient scaffolding of coronary arteries? A pooled analysis of …
arteriosclerosis, drives transient scaffolding of coronary arteries? A pooled analysis of …